These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18788838)

  • 1. Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study.
    Tuchman MM; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2008; 22(10):877-86. PubMed ID: 18788838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
    Loder E; Silberstein SD; Abu-Shakra S; Mueller L; Smith T
    Headache; 2004 Feb; 44(2):120-30. PubMed ID: 14756849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
    Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
    Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
    Loder E; Freitag FG; Adelman J; Pearlmand S; Abu-Shakra S
    Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
    Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.
    Rapoport AM; Ramadan NM; Adelman JU; Mathew NT; Elkind AH; Kudrow DB; Earl NL
    Neurology; 1997 Nov; 49(5):1210-8. PubMed ID: 9371896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
    Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
    Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Tepper SJ; Dodick DW; Schmidt PC; Kellerman DJ
    Headache; 2019 Apr; 59(4):509-517. PubMed ID: 30698272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
    Dowson AJ; MacGregor EA; Purdy RA; Becker WJ; Green J; Levy SL
    Cephalalgia; 2002 Mar; 22(2):101-6. PubMed ID: 11972576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
    Spierings EL; Brandes JL; Kudrow DB; Weintraub J; Schmidt PC; Kellerman DJ; Tepper SJ
    Cephalalgia; 2018 Feb; 38(2):215-224. PubMed ID: 29022755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of zolmitriptan nasal spray in adolescent migraine.
    Lewis DW; Winner P; Hershey AD; Wasiewski WW;
    Pediatrics; 2007 Aug; 120(2):390-6. PubMed ID: 17671066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group.
    Solomon GD; Cady RK; Klapper JA; Earl NL; Saper JR; Ramadan NM
    Neurology; 1997 Nov; 49(5):1219-25. PubMed ID: 9371897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
    Geraud G; Compagnon A; Rossi A;
    Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.